The second day of DDL 23 got underway with an invited talk from OINDP consultant Steve Nichols who reviewed the state of the inhaled drug market in 2012 with a promise to answer the question, "Is there much happening in the inhaled area at the moment?" Among the collaborations announced during 2012, Nichols pointed out, there were more licensing deals than mergers, … [Read more...] about DDL 23 — Day 2
Features
DDL 23 — Day 1
Meeting chair Gary Pitcairn started off DDL 23 with the announcement of some attendance statistics: just under 500 attendees have registered for this year's meeting, with 35% of them from pharma companies, 17% from academia, and 48% from "service industries." Attendees from Europe make up 88% of the total, with 6% from North America, and another 6% from the rest of … [Read more...] about DDL 23 — Day 1
2012 AAPS annual meeting
The 2012 annual meeting of the American Association of Pharmaceutical Scientists, which took place from October 14-18 at the McCormick Place convention center in Chicago, drew a number of inhalation and nasal specialists for the focus group meeting, poster sessions, symposia, and exposition. During the Inhalation and Nasal Technology Focus Group (INTFG) business … [Read more...] about 2012 AAPS annual meeting
DDL 23 organizers anticipate record attendance
The organizers of Drug Delivery to the Lungs (DDL) 23, which will take place December 5-7 at the Edinburgh International Conference Centre in Edinburgh, UK, are preparing to accommodate a record number of attendees. Committee members Mark Hammond and Ben Forbes say that they expect more than 500 OINDP specialists at DDL this year, a mark the meeting just missed in … [Read more...] about DDL 23 organizers anticipate record attendance
Gateway Analytical to host INTFG Fall Symposium
Contract particle characterization specialist Gateway Analytical has announced that it will host the 2012 Inhalation and Nasal Technology Focus Group (INTFG) Annual Fall Symposium on September 7, 2012 at the Pittsburgh North Marriott in Cranberry, PA. The 2012 symposium, titled "Excipients for Pulmonary Delivery--Challenges and Opportunities," will feature … [Read more...] about Gateway Analytical to host INTFG Fall Symposium
Young designers re-imagine the inhaler
Entries submitted to several student inhaler and medical device design contests over the past year envision some radical changes in inhaler design. These concepts, created by students who range in age from primary school through college, provide some insight into the students' priorities when it comes to inhalation devices -- all of the inhalers they created emphasize … [Read more...] about Young designers re-imagine the inhaler
A Q&A with Tim Noakes of MexiChem, Part 2
Tim Noakes has been Medical Propellants Business Expert at Mexichem over the last 20+ years and has developed unique access to and insight into pressurized metered dose inhaler manufacturing around the world. He gives OINDPnews.com his perspective on how the industry has been evolving, especially in the developing world. Read Part 1 Q: What trends are you … [Read more...] about A Q&A with Tim Noakes of MexiChem, Part 2
A Q&A with Tim Noakes of MexiChem, Part 1
As Medical Propellants Business Expert at Mexichem over the last 20+ years, Tim Noakes has developed unique access to and insight into pressurized metered dose inhaler manufacturing around the world. He gives OINDPnews.com his perspective on how the industry has been evolving, especially in the developing world. Q:What has been the most significant change in MDI … [Read more...] about A Q&A with Tim Noakes of MexiChem, Part 1
From inhalable vaccines to inhalable caffeine (updated March 7, 2012)
Update 3/7/2012: The FDA issues a warning letter on inhalable caffeine. Update 2/19/2012: The FDA says it will review the safety and legality of AeroShot inhaled caffeine. In 2008, Harvard professor David Edwards gave a talk to the AAPS Inhalation and Nasal Technology Focus Group (INTFG) titled "Inhaled Drugs and Vaccines for Infectious Diseases in Low-Income … [Read more...] about From inhalable vaccines to inhalable caffeine (updated March 7, 2012)
Aerosol School offers comprehensive introduction to inhaled and nasal drugs
In early April, up to 20 scientists, technicians, and students from around the world will gather in a laboratory at the Firestone Institute for Respiratory Health in Hamilton, Ontario, Canada for an intensive course known as "Aerosol School." Over a three-day period, the 20 participants from industry and academia will learn the basics of aerosol medicine formulation, … [Read more...] about Aerosol School offers comprehensive introduction to inhaled and nasal drugs